Treatment Outcomes of Three-Dimensional Conformal Radiotherapy for Stage III N on-Small Cell Lung Cancer

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the treatment outcomes of the three-dimensional conformal radiotherapy (3D-CRT), in conjunction with induction chemotherapy, for the treatment of stage III non-small cell lung cancer (NSCLC). Materials and Methods: Between November 1998 and March 2003, 22 patients with histologically proven, clinical stage III NSCLC, treated with induction chemotherapy,followed by 3D-CRT, were retrospectively analyzed. There were 21 males (96%) and 1 female (4%), with a median age of 68.5 (range, 42∼79). The clinical cancer stages were IIIA and IIIB in 41 and 59%, respectively. The histologies were squamous cell carcinoma, adenocarcinoma and others in 73, 18 and 9%, respectively. Twenty patients (91%) received induction chemotherapy before radiation therapy. The majority of the chemotherapy regimen consisted of cisplatin and gemcitabine. Radiation was delivered with conventional anteroposterior/ posteroanterior fields for 36 Gy, and then 3D-CRT was performed. The total radiation dose was 70.2 Gy. The median follow-up period was 17 months (range, 4∼59 months).Results: The median overall survival was 19 months. The two and four-year overall survival rates were 37.9 and 30.3%, respectively. The median progression-free survival was 21 months. The two and four-year progression-free survival rates were 42.1 and 21%, respectively. The prognostic factors for overall survival by a univariate analysis were age, histology and T stage (p〈0.05). Acute radiation toxicities, as evaluated by the RTOG toxicity criteria, included two cases of grade 3 lung toxicity and one case of grade 2 esophagus toxicity.Conclusion: The radiation dose could be increased without a significant increment in the acute toxicities when using 3D-CRT. It also seems to be a safe, welltoleratedand effective treatment modality for stage III NSCLC.

참고문헌 (Reference)

1 "criticalprognostic factor in patients treated with three-dimensionalconformal radiation therapy for non-small cell lung carcinoma" ieumwana (ieumwana): 49-57, 2002

2 "comparison of free-breathing and breathholdtechniques" 60 : 419-26, 2004

3 "WHO handbook for reporting results of cancer treatments" 1979

4 "The treatment of stage III non small cell lungcancer using high dose conformal radiotherapy" 33 : 1001-7, 1995

5 "Results of high-dose thoracicirradiation incorporating beam's eye view display in non-smallcell lung cancer:a retrospective multivariate analysis" 27 : 273-84, 1993

6 "Reproducibility oflung tumor position and reduction of lung mass within theplanning target volume using active breathing control (ABC)." 57 : 1437-42, 2003

7 "Radiotherapy alone versus combined chemotherapyand radiotherapy in nonresectable non-small-cell lungcancer:first analysis of a randomized trial in 353 patients" 83 : 417-23, 1991

8 "Promising survival with three-dimensional conformalradiation therapy for non small cell lung cancer" 44 : 17-22, 1997

9 "Phase III comparison of sequential vs concurrentchemoradiation for patients with unresected stage III non-smallcell lung cancer initial report of Radiation TherapyOncology Group" 20001891a

10 "Long-term observations of the patterns offailure in patients with unresectable non-oat cell carcinoma ofthe lung treated with definitive radiotherapy:a report by theRadiation Therapy Oncology Group" 59 : 1874-81, 1987

11 "Interruptions of high-dose radiation therapy decreaselong-term survival of favorable patients with unresectablenon-small cell carcinoma of the lung Analysis of 1244 casesfrom 3 Radiation Therapy Oncology Group" 493-8, 1993

12 "Induction chemotherapy plus three-dimensional conformal radiationtherapy in the definitive treatment of locally advancednon-small cell lung cancer" 51 : 660-5, 2001

13 "Induction and concurrent chemotherapywith high-dose thoracic conformal radiation therapy in unresectablestage IIIA and IIIB non-small-cell lung cancer:adose-escalation phase I trial" 22 : 4341-50, 2004

14 "Improved survival in stage III non-small cell lung cancer:seven-year follow-up of Cancer and Leukemia Group B(CALGB) 8433 trial." 88 : 1210-5, 1996

15 "Elective nodal irradiation in thetreatment of non-small cell lung cancer with three-dimensionalconformal radiation therapy" 50 : 681-5, 2001

16 "Dose escalation for non-small cell lungcancer using conformal radiation therapy" 37 : 1079-85, 1997

17 "Concurrent chemoradiation therapy with cisplatin andoral etoposide for locally advanced non-small cell lung cancer" 32 : 682-9, 2000

18 "Clinical dose-volume histogram analysis forpneumonitis after 3D treatment for non-small cell lung cancer(NSCLC)." 45 : 323-9, 1999

19 "Chemotherapy in non-small cell lung cancer: a meta-analysisusing updated data on individual patients from 52 randomisedclinical trials." 311 : 899-909, 1995

20 "Can elective nodal irradiationbe omitted in stage III non-small-cell lung cancer? Analysisof recurrences in a phase II study of induction chemotherapyand involved-field radiotherapy." 54 : 999-1006, 2002

21 "Beam's eye View volumetrics:an aid in rapid treatment plan development and evaluation" 23 : 367-75, 1992

22 "Beam's Eye View-based photon radiotherapyI" 21 : 1575-86, 1991

23 "A randomized trial of induction chemotherapyplus high-dose radiation versus radiation alone in stage IIInon-small-cell lung cancer" 323 : 940-5, 1990

24 "A randomized phase I/II trial of hyperfractionated radiationtherapy with total doses of 60 0 Gy to 79 possiblesurvival benefit with 69 6 Gy in favorable patients withRadiation Therapy Oncology Group stage III non small celllung carcinoma report of Radiation Therapy Oncology Group83-11" 2 1543-55, 1990

25 "A prospective randomized study of variousirradiation doses and fractionation schedules in the treatmentof inoperable non-oat-cell carcinoma of the lung:preliminaryreport by the Radiation Therapy Oncology Group" 45 : 2744-53, 1980